Photo credit: www.sciencedaily.com
Researchers at University of Galway have developed an extensive collection of digital microbes, comprising nearly 250,000 computer models, designed to enhance our knowledge of the human microbiome and its implications for health.
This study is centered on the bacterial microbiome—the diverse groups of bacteria existing within and on our bodies.
The research team has launched APOLLO, a groundbreaking database consisting of 247,092 advanced computer models, each reflecting the unique metabolic processes of specific microbes residing within these communities.
This innovative database empowers scientists to utilize computational tools to examine microbial functions within the human body and their connections to health and disease, significantly streamlining research efforts that typically depend on complex experiments involving live organisms.
APOLLO spans multiple countries, age demographics, and physical locations, establishing itself as the largest computational model repository concerning the human microbiome to date.
This research initiative represents a culmination of the team’s decade-long experience, expanding from earlier projects such as AGORA, which included hundreds of microbes, and AGORA2, with thousands.
Moreover, the team generated 14,451 computer simulations of individual microbiome communities based on actual sample data, offering insights into how microbial metabolism varies according to body site, age, and specific health conditions. These simulations also identified important fecal metabolites associated with conditions like Crohn’s disease, Parkinson’s disease, and undernutrition in children, potentially guiding future approaches to diagnostics and treatment.
The project was executed by scientists at the Digital Metabolic Twin Centre at University of Galway, under the leadership of Professor Ines Thiele, who serves as a principal investigator with APC Microbiome Ireland—a research center focused on microbiological communities, based at University College Cork.
Professor Thiele’s research team utilizes computational modeling to push the boundaries of precision health.
Potential Benefits of APOLLO:
Improved diagnostics – The identification of microbial metabolic markers through APOLLO could lead to the development of non-invasive diagnostic methods, facilitating earlier and more precise diagnoses.
Personalized treatments – The simulations may provide insights into how an individual’s microbiome interacts with various factors such as diet and medications, paving the way for tailored treatments that enhance gut health and optimize responses to therapies.
Drug development and probiotics – The insights gained could inform the design of targeted probiotics, prebiotics, and microbiome-based therapeutic strategies aimed at effectively treating specific health issues.
Public Health insights – By incorporating a wide variety of microbiomes, APOLLO offers a comprehensive perspective that can address the influence of contemporary lifestyles on microbiome health. This knowledge can inform public health initiatives related to antibiotic use, dietary choices, and disease prevention.
Dr. Cyrille Thinnes, a scientist involved in the project, stated: “APOLLO signifies a significant breakthrough in personalized microbiome modeling on a global scale. Our microbiome is integral to functions such as digestion and immune response, and understanding its impact on various health conditions, including those affecting the gut and the brain, is crucial for innovating new diagnostic methods, treatments, and personalized healthcare strategies.
“With its broad inclusion of microbial diversity across different regions, demographics, and body locations, APOLLO addresses vital gaps in global health research. It tackles urgent issues regarding the effects of Western lifestyles—marked by sedentary behavior, processed food consumption, and excessive antibiotic use—on microbial diversity and function. By integrating information about underrepresented non-Western populations and various bodily sites beyond the gut, APOLLO emerges as an essential resource for advancing microbiome research and its practical applications.”
Professor Ines Thiele, the study’s principal investigator, remarked: “The human microbiome plays a crucial role in both health and disease, continuously interacting with the host organism. Gaining insight into these intricate interactions necessitates sophisticated technology. Our research combines digital representations of microbes and humans, enabling a detailed exploration of the microbiome’s influence on health.
“APOLLO enhances this approach by encompassing microbiome communities in a manner that facilitates personalization on a global scale.
“Over the last ten years, our work has evolved from a singular, generic human model to intricate models that take into account variables such as biological sex, physiological characteristics, and specific organs. Likewise, we progressed from examining a limited number of microbes to representing hundreds of thousands. These models are capable of integrating data related to individual dietary patterns and health conditions, thereby fostering the development of testable hypotheses and tailored health recommendations. APOLLO represents a significant advancement in the shift towards digital twin-based precision healthcare, propelling us closer to customized health solutions for individuals worldwide.”
Source
www.sciencedaily.com